Global Patterns and Trends in Female Infertility Linked to STIs (1990-2021)
Overview
This report evaluates the global burden of female infertility attributable to sexually transmitted infections (STIs) from 1990 to 2021, highlighting significant regional disparities and the impact of preventable infections. The findings underscore the need for targeted interventions to improve reproductive health outcomes worldwide.
Background
Infertility affects 8%-12% of reproductive-aged individuals globally, with female factors contributing to 40%-50% of cases. STIs are implicated in nearly 30% of female infertility cases, leading to conditions such as pelvic inflammatory disease and tubal factor infertility. Understanding the epidemiological trends of STIs-related infertility is crucial for developing effective public health strategies.
Approximately 30% of female infertility cases are attributable to STIs.
Chlamydia trachomatis and Neisseria gonorrhoeae are the primary pathogens linked to STIs-related infertility.
Significant regional disparities exist in the burden of STIs-induced female infertility, particularly in lower-SDI regions.
Access to assisted reproductive technologies is limited in low- and middle-income countries, exacerbating infertility challenges.
Recent trends indicate a sustained high burden of STIs, necessitating improved prevention and treatment strategies.
Clinical Implications
Healthcare providers should prioritize screening and treatment for STIs in reproductive-aged women to mitigate the risk of infertility. Enhanced access to reproductive health services, particularly in low-resource settings, is essential for addressing the preventable causes of female infertility.
Conclusion
The findings highlight the critical role of STIs in female infertility and the urgent need for targeted public health interventions to reduce their impact on reproductive health globally.
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
